DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viread (Tenofovir Disoproxil) - Abortion Spontaneous - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Abortion Spontaneous (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viread (Tenofovir Disoproxil) where reactions include abortion spontaneous. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Viread side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-05-28

Isentress
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23

Kaletra
    Dosage: 4 df, unk
    Administration route: Oral
    Start date: 2012-05-28

Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from Argentina on 2012-08-08

Patient: 37 year old female

Reactions: Endometrial Disorder, Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Kaletra
    Dosage: 4tab unknown
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21



Possible Viread side effects in 35 year old female

Reported by a physician from Mexico on 2012-08-06

Patient: 35 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Raltegravir
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient:

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: unk df, unk
    Administration route: Oral
    Start date: 2012-05-28

Isentress
    Dosage: unk mg, unk
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23

Kaletra
    Dosage: unk df, unk
    Administration route: Oral
    Start date: 2012-05-28

Viread
    Dosage: unk mg, unk
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 37 year old female

Reactions: Endometrial Disorder, Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Kaletra
    Dosage: 4tab unknown
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21



Possible Viread side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from Mexico on 2012-07-23

Patient: 35 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Reyataz
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in 44 year old female

Reported by a physician from Thailand on 2012-07-16

Patient: 44 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Norvir
    Dosage: 150mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14



Possible Viread side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient: 44 year old female

Reactions: Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Dosage: not taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2012-03-14

Kaletra
    Dosage: not taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2012-03-14

Norvir
    Dosage: 150 mg daily; taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-11-03
    End date: 2012-03-12

Reyataz
    Dosage: 300 mg daily; taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-11-03
    End date: 2012-03-12

Truvada
    Dosage: 1 tabs/caps daily; taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Dosage: not taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2012-03-14



Possible Viread side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-03

Patient: 44 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Norvir
    Dosage: 150mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Reyataz
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014